Astellas Pharma Inc. (ALPMF)
OTC: ALPMF
· Real-Time Price · USD
11.10
0.00 (0.00%)
At close: Aug 08, 2025, 2:03 PM
Astellas Pharma Cash Flow Statement
Financials in JPY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | 50.75B | -57.43B | 61.69B | 31.11B | 40.35B | 25.75B | 64.06B | 147.53B | 132.36B | 169.72B | 188.28B | 152.74B | 156.89B | 148.5B | 145.32B | 120.92B | 145.32B | 170.39B | 172.86B | 229.06B |
Depreciation & Amortization | 199.13B | 200.09B | 195.91B | 184.86B | 157.84B | 132.21B | 108.23B | 92.11B | 105.74B | 103.8B | 102.33B | 98.41B | 79.68B | 77.16B | 73.79B | 72.8B | 72.65B | 72.19B | 71.19B | 67.38B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 37.55B | 55.83B | 70.38B | 76.88B | 34.82B | 80.99B | 94.28B | 59.53B | 98.19B | 22.5B | 4.58B | 22.73B | -30.09B | 5.54B | -25.25B | -19.11B | -29.41B | -19.45B | -39.24B | -14.2B |
Other Non-Cash Items | 85.12B | 214.3B | 88.77B | 105.42B | 138.35B | 121.25B | 120.07B | 87.05B | 113.88B | 33.6B | -12.05B | 14.39B | 14.92B | 40.6B | 114.63B | 141.59B | 120.59B | 60.3B | 34.89B | -40.3B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -140.49B | -95.71B | -49.73B | -52.69B | -68.24B | -63.12B | -55.36B | -35.56B | -24.21B | -46.36B | -20.65B | 652M | 5.96B | 24.3B | -2.47B | -9.98B | -31.73B | -26.03B | -43.63B | -19.96B |
Operating Cash Flow | 194.51B | 167.99B | 203.38B | 175.45B | 175.05B | 216.09B | 236.99B | 291.13B | 327.77B | 260.76B | 257.92B | 266.19B | 257.44B | 290.56B | 331.27B | 325.33B | 306.84B | 276.85B | 235.3B | 236.19B |
Capital Expenditures | -37B | -47.23B | -64.79B | -80.13B | -82.5B | -90.69B | -96.16B | -86.64B | -88.54B | -77.69B | -68.26B | -74.8B | -76.45B | -77.75B | -82.28B | -64.09B | -77.44B | -80.17B | -88.55B | -100.65B |
Cash Acquisitions | n/a | -190M | -24.92B | -784.97B | -784.97B | -784.78B | -760.05B | n/a | n/a | -11M | -21M | -22M | -670M | -672M | -13.86B | -13.9B | -14.92B | -322.75B | -317.39B | -317.29B |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 456M | 520M | 520M | 520M | 64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -52.42B | -63.77B | -31.06B | -10.32B | 19.09B | 28.66B | 22.51B | 8.47B | 3.52B | 1.03B | 18.4B | -14.03B | -13.67B | -11.7B | -23.04B | 3.34B | 10.46B | 19.78B | 24.42B | 13.81B |
Investing Cash Flow | -89.42B | -111.19B | -120.78B | -875.43B | -848.38B | -846.36B | -833.17B | -77.66B | -84.5B | -76.61B | -41.33B | -60.47B | -62.41B | -61.74B | -99.35B | -74.65B | -81.89B | -383.14B | -381.52B | -404.14B |
Debt Repayment | -65.15B | 1.51B | 18.2B | 34.69B | 44.24B | -48.88B | -50B | -50B | -35B | -5B | -5B | -5B | -20B | -45B | -64B | -96B | -126B | -81B | -62B | -30B |
Common Stock Repurchased | -6.96B | -6.96B | -6.96B | -6.96B | -10.73B | -60.73B | -60.73B | -60.73B | -60.56B | -60.56B | -60.55B | -60.56B | -50.72B | -9B | -9B | -9B | -9.16B | -15.72B | -52.59B | -53.78B |
Dividend Paid | -128.99B | -128.99B | -125.51B | -125.51B | -116.65B | -116.65B | -108.58B | -108.58B | -100.36B | -100.36B | -92B | -92B | -85.24B | -85.24B | -77.92B | -77.92B | -76.16B | -76.16B | -74.86B | -74.86B |
Other Financial Acitivies | -60.26B | -5.18B | -8.09B | 534.88B | 697.21B | 704.89B | 775.28B | 235.34B | 288M | -243M | -50.24B | -60.61B | -60.34B | -60.17B | -58.76B | -18.32B | -18.16B | 307.83B | 306.73B | 307.07B |
Financial Cash Flow | -261.37B | -139.63B | -122.36B | 437.1B | 614.06B | 478.63B | 555.96B | 16.02B | -195.62B | -166.15B | -207.79B | -218.17B | -216.3B | -199.41B | -209.68B | -201.23B | -229.48B | 134.95B | 117.28B | 148.43B |
Net Cash Flow | 188.37B | 261.57B | 1.69B | 77.13B | -41.15B | -127.84B | -27.08B | 248.47B | 60.85B | 31.6B | 42.78B | 11.09B | -10.14B | 43.7B | 31.56B | 61.99B | 7.74B | 28.91B | -24.63B | -19.49B |
Free Cash Flow | 157.51B | 120.76B | 138.59B | 95.32B | 92.55B | 125.4B | 140.84B | 204.49B | 239.23B | 183.06B | 189.65B | 191.4B | 181B | 212.8B | 248.99B | 261.24B | 229.4B | 196.68B | 146.75B | 135.53B |